We are live on
!
Find out more
FPC
Falcon Point Capital Portfolio holdings
AUM
$11.9M
1-Year Est. Return
55.76%
This Fund
S&P 500
This Quarter
Est. Return
+5.3%
1 Year Est. Return
+55.76%
3 Year Est. Return
+118.89%
5 Year Est. Return
+197.9%
10 Year Est. Return
–
AUM
$186M
AUM Growth
+$2.38M
(+1.3%)
Cap. Flow
-$2.65M
Cap. Flow
% of AUM
-1.43%
Top 10 Holdings %
Top 10 Hldgs %
31.53%
Holding
115
New
9
Increased
51
Reduced
28
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RCM
R1 RCM Inc. Common Stock
RCM
|
+$4.02M |
| 2 |
Coherent
COHR
|
+$2.39M |
| 3 |
BrightView Holdings
BV
|
+$2.08M |
| 4 |
ICF International
ICFI
|
+$1.82M |
| 5 |
CONN
Conn's Inc.
CONN
|
+$1.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Integra LifeSciences
IART
|
+$3.02M |
| 2 |
BFYT
Benefytt Technologies, Inc. Class A Common Stock
BFYT
|
+$2.69M |
| 3 |
Central Garden & Pet Co Class A
CENTA
|
+$2.63M |
| 4 |
Travere Therapeutics
TVTX
|
+$1.77M |
| 5 |
NVTR
Nuvectra Corporation Common Stock
NVTR
|
+$1.61M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 28.92% |
| 2 | Technology | 18.68% |
| 3 | Healthcare | 12.11% |
| 4 | Consumer Discretionary | 11.2% |
| 5 | Communication Services | 5.24% |
Similar funds
GFWEX
SAM
VAIA
HAM
AIDCT
RC
NCM
GBA
Falcon Point Capital's Q2 2019 Portfolio in Review
As of Q2 2019, Falcon Point Capital held 115 positions worth $186M, up 1.3% from $184M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Falcon Point Capital's Q2 2019 filing shows 9 new, 51 increased, 28 reduced and 10 closed positions. Its largest new stake was Coherent: 65,530 shares worth $2.4M. The largest sale was Integra LifeSciences, an estimated $3.02M.
By sector, the portfolio is most concentrated in Industrials at 29% of assets, up from 23% a quarter earlier, followed by Technology and Healthcare.
- Falcon Point Capital's largest Q2 2019 buy was Coherent: 65,530 shares worth $2.4M.
- Falcon Point Capital added most to R1 RCM Inc. Common Stock in Q2 2019, an estimated $4.02M increase.
- Falcon Point Capital's biggest Q2 2019 reduction was Integra LifeSciences, cutting an estimated $3.02M.
- Falcon Point Capital fully exited Benefytt Technologies, Inc. Class A Common Stock in Q2 2019, selling an estimated $2.69M.
- Falcon Point Capital's ten largest holdings make up 32% of its $186M portfolio in Q2 2019.
- Falcon Point Capital opened 9 new positions and closed 10 in Q2 2019.
- Falcon Point Capital's portfolio value rose 1.3% quarter-over-quarter to $186M.
Based on Falcon Point Capital's 13F filing for Q2 2019, filed 15 Jul 2019.